Need Help? Talk to an Expert +1 (408) 836-7136

Categorized Chronological Ownerhip by owner Transcripts Expert Interviews Holdings Your Highlights Financial Information Proxy/Share Holder Meeting Insider Transactions Beneficial Ownership/Institutional ownership Merger/Acquisition IPO/Public Offerings Securities-based Crowdfunding Regulation A Offering Foreign Private Issuers Mutual Funds and ETFs Variable Annuities Exhibits Delisitngs Deregister

  ArriVent BioPharma, Inc.   |  1868279

Financials Total:6
Form Type Act Filing Date Report Date Action
10-Q 34 05/08/2024 03/31/2024 |    |  
8-K 34 05/08/2024 05/08/2024 |    |  
8-K 34 04/22/2024 04/20/2024 |    |  
10-K 34 03/28/2024 12/31/2023 |    |  
8-K 34 03/28/2024 03/28/2024 |    |  
8-K 34 01/30/2024 01/30/2024 |    |  
Ipos Total:8
Form Type Act Filing Date Report Date Action
CORRESP 01/23/2024 05/13/2024
CORRESP 01/23/2024 05/13/2024
CORRESP 01/22/2024 05/13/2024
UPLOAD 01/12/2024 05/13/2024
CORRESP 01/11/2024 05/13/2024
S-1 33 01/05/2024 05/13/2024
UPLOAD 10/18/2023 05/13/2024
UPLOAD 09/27/2023 05/13/2024
Form Type Act Filing Date Report Date Action
4 04/23/2024 04/22/2024
3 04/23/2024 04/20/2024
4 02/01/2024 01/30/2024
4 01/31/2024 01/30/2024
4 01/31/2024 01/30/2024
4 01/31/2024 01/30/2024
4 01/29/2024 01/25/2024
4 01/29/2024 01/25/2024
3 01/25/2024 01/25/2024
3 01/25/2024 01/25/2024
Show More
Form Type Act Filing Date Report Date Action
SC 13G 34 02/13/2024 05/13/2024
SC 13D 34 02/05/2024 05/13/2024
Form Type Act Filing Date Report Date Action
8-K 34 05/08/2024 05/08/2024 |    |  
8-K 34 04/22/2024 04/20/2024 |    |  
8-K 34 03/28/2024 03/28/2024 |    |  
8-K 34 01/30/2024 01/30/2024 |    |  
Form Type Act Filing Date Report Date Action
S-1/A 33 01/23/2024 05/13/2024
S-1/A 33 01/22/2024 05/13/2024
S-1 33 01/05/2024 05/13/2024